By Professor Ric Day

Journal articles

Leopoldino AO; MacHado GC; Ferreira PH; Pinheiro MB; Day R; McLachlan AJ; Hunter DJ; Ferreira ML, 2019, 'Paracetamol versus placebo for knee and hip osteoarthritis', Cochrane Database of Systematic Reviews, 2019, http://dx.doi.org/10.1002/14651858.CD013273

Day RO; Lau W; Stocker SL; Aung E; Coleshill MJ; Schulz M; Bechara J; Carland JE; Graham GG; Williams KM; McLachlan AJ, 2019, 'Management of gout in older people', Journal of Pharmacy Practice and Research, 49, pp. 90 - 97, http://dx.doi.org/10.1002/jppr.1511

Milder TY; Stocker SL; Shaheed CA; McGrath-Cadell L; Samocha-Bonet D; Greenfield JR; Day RO, 2019, 'Combination Therapy with an SGLT2 Inhibitor as Initial Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis', JOURNAL OF CLINICAL MEDICINE, 8, http://dx.doi.org/10.3390/jcm8010045

Baysari M; Del Gigante J; Moran M; Lehnbom E; Day R, 2019, 'Mandatory Medication Indications in Electronic Systems a he Prescriber Perspective', , 265, pp. 95 - 100, http://dx.doi.org/10.3233/SHTI190145

Shingde RV; Graham GG; Reuter SE; Carland JE; Day RO; Stocker SL, 2019, 'Comparison of the Area Under the Curve for Vancomycin Estimated Using Compartmental and Noncompartmental Methods in Adult Patients With Normal Renal Function.', Ther Drug Monit, 41, pp. 726 - 731, http://dx.doi.org/10.1097/FTD.0000000000000690

Sindone J; Day R; Stefani M; Joseph J, 2019, 'Perioperative Management of Antiplatelets in Elective Surgery at a Tertiary Hospital', Heart, Lung and Circulation, 28, pp. S370 - S370, http://dx.doi.org/10.1016/j.hlc.2019.06.553

Imani S; Buscher H; Day R; Gentili S; Jones GRD; Marriott D; Norris R; Sandaradura I, 2018, 'An evaluation of risk factors to predict target concentration non-attainment in critically ill patients prior to empiric β-lactam therapy', European Journal of Clinical Microbiology and Infectious Diseases, 37, pp. 2171 - 2175, http://dx.doi.org/10.1007/s10096-018-3357-9

Chan JOS; Baysari MT; Carland JE; Sandaradura I; Moran M; Day RO, 2018, 'Barriers and facilitators of appropriate vancomycin use: prescribing context is key', European Journal of Clinical Pharmacology, 74, pp. 1523 - 1529, http://dx.doi.org/10.1007/s00228-018-2525-2

Baysari MT; Lowenstein D; Zheng WY; Day RO, 2018, 'Reliability, ease of use and usefulness of I-MeDeSA for evaluating drug-drug interaction alerts in an Australian context', BMC medical informatics and decision making, 18, pp. 83, http://dx.doi.org/10.1186/s12911-018-0666-y

Kumar SS; McManus H; Radovich T; Greenfield JR; Viardot A; Williams KM; Cronin P; Day RO, 2018, 'Interrogation of a longitudinal, national pharmacy claims dataset to explore factors that predict the need for add-on therapy in older and socioeconomically disadvantaged Australians with type 2 diabetes mellitus patients (T2DM)', European Journal of Clinical Pharmacology, 74, pp. 1327 - 1332, http://dx.doi.org/10.1007/s00228-018-2506-5

Carland JE; Smith FC; Day RO, 2018, 'Lactic Acidosis, Metformin Use, and Dose-Response Association', JAMA Internal Medicine, 178, pp. 1428 - 1429, http://dx.doi.org/10.1001/jamainternmed.2018.4448

Nguyen AD; Frensham LJ; Wong MXC; Meslin SMM; Martin P; Lau AYS; Baysari MT; Day RO, 2018, 'mHealth app patient testing and review of educational materials designed for self-Management of gout patients: Descriptive qualitative studies', Journal of Medical Internet Research, 20, http://dx.doi.org/10.2196/mhealth.9811

Graham GG; Stocker SL; Kannangara DRW; Day RO, 2018, 'Predicting Response or Non-response to Urate-Lowering Therapy in Patients with Gout', Current Rheumatology Reports, 20, http://dx.doi.org/10.1007/s11926-018-0760-2

Nguyen AD; Frensham LJ; Baysari MT; Carland JE; Day RO, 2018, 'Patients' use of mobile health applications: What general practitioners think', Family Practice, 36, pp. 214 - 218, http://dx.doi.org/10.1093/fampra/cmy052

Counsell AB; Nguyen AD; Baysari MT; Kannangara DRW; McLachlan AJ; Day RO, 2018, 'Exploring current and potential roles of Australian community pharmacists in gout management: A qualitative study', BMC Family Practice, 19, http://dx.doi.org/10.1186/s12875-018-0744-3

Indraratna PL; Virk S; Gurram D; Day RO, 2018, 'Use of colchicine in pregnancy: A systematic review and meta-analysis', Rheumatology (United Kingdom), 57, pp. 382 - 387, http://dx.doi.org/10.1093/rheumatology/kex353

Nguyen AD; Frensham LJ; Wong MXC; Meslin SMM; Martin P; Lau AY; Baysari MT; Day RO, 2018, 'Patient testing of a mobile health app and review of educational materials designed for gout patient self-management (Preprint)', , http://dx.doi.org/10.2196/preprints.9811

Ma CKK; Danta M; Day R; Ma DDF, 2018, 'Dealing with the spiralling price of medicines: issues and solutions', Internal Medicine Journal, 48, pp. 16 - 24, http://dx.doi.org/10.1111/imj.13652

Zheng WY; Richardson LC; Li L; Day RO; Westbrook JI; Baysari MT, 2018, 'Drug-drug interactions and their harmful effects in hospitalised patients: a systematic review and meta-analysis', European Journal of Clinical Pharmacology, 74, pp. 15 - 27, http://dx.doi.org/10.1007/s00228-017-2357-5

Meslin SMM; Zheng WY; Day RO; Tay EMY; Baysari MT, 2018, 'Evaluation of Clinical Relevance of Drug-Drug Interaction Alerts Prior to Implementation', Applied Clinical Informatics, 9, pp. 849 - 855, http://dx.doi.org/10.1055/s-0038-1676039

Lin CWC; Li Q; Williams CM; Maher CG; Day RO; Hancock MJ; Latimer J; Mclachlan AJ; Jan S, 2018, 'The economic burden of guideline-recommended first line care for acute low back pain', European Spine Journal, 27, pp. 109 - 116, http://dx.doi.org/10.1007/s00586-016-4781-0

Day R; Kamel B; Graham GG; Williams KM; Stocker SL; Carland JE; Pile KD; Mcguigan LE; Portek IJ; Mcgill NW, 2018, 'A Multicentre Open-Label Pharmacokinetic-Pharmacodynamic Study of Febuxostat in Patients with Chronic Gout', Proceedings for Annual Meeting of The Japanese Pharmacological Society, WCP2018, http://dx.doi.org/10.1254/jpssuppl.wcp2018.0_po1-11-12

Maali Y; Perez-Concha O; Coiera E; Roffe D; Day RO; Gallego B, 2018, 'Predicting 7-day, 30-day and 60-day all-cause unplanned readmission: a case study of a Sydney hospital', BMC medical informatics and decision making, 18, pp. 1 - 11, http://dx.doi.org/10.1186/s12911-017-0580-8

Shaheed CA; Mathieson S; Day RO; Maher CG; McLACHLAN AJ; McLACHLAN H; Lin CWC, 2017, 'What is the evidence for opioid analgesia for low back pain?', Medicine Today, 18, pp. 24 - 27

Jones G; Panova E; Day R, 2017, 'Guideline development for the management of gout: Role of combination therapy with a focus on lesinurad', Drug Design, Development and Therapy, 11, pp. 3077 - 3081, http://dx.doi.org/10.2147/DDDT.S97959

Day RO; Frensham LJ; Nguyen AD; Baysari MT; Aung E; Lau AYS; Zwar N; Reath J; Laba T; Li L; McLachlan A; Runciman WB; Buchbinder R; Clay-Williams R; Coiera E; Braithwaite J; McNeil HP; Hunter DJ; Pile KJ; Portek I; Williams KM; Westbrook JI, 2017, 'Effectiveness of an electronic patient-centred self-management tool for gout sufferers: A cluster randomised controlled trail protocol', BMJ Open, 7, pp. e017281, http://dx.doi.org/10.1136/bmjopen-2017-017281

Wiles LK; Hibbert PD; Stephens JH; Coiera E; Westbrook J; Braithwaite J; Day RO; Hillman KM; Runciman WB, 2017, 'STANDING Collaboration: A study protocol for developing clinical standards', BMJ Open, 7, pp. e014048, http://dx.doi.org/10.1136/bmjopen-2016-014048

Duong JK; Kroonen MYAM; Kumar SS; Heerspink HL; Kirkpatrick CM; Graham GG; Williams KM; Day RO, 2017, 'A dosing algorithm for metformin based on the relationships between exposure and renal clearance of metformin in patients with varying degrees of kidney function', European Journal of Clinical Pharmacology, 73, pp. 981 - 990, http://dx.doi.org/10.1007/s00228-017-2251-1

Ramanathan SA; Hibbert PD; Maher CG; Day RO; Hindmarsh DM; Hooper TD; Hannaford NA; Runciman WB, 2017, 'CareTrack', Spine, 42, pp. E802 - E809, http://dx.doi.org/10.1097/BRS.0000000000001972

Machado GC; Maher CG; Ferreira PH; Day RO; Pinheiro MB; Ferreira ML, 2017, 'Non-steroidal anti-inflammatory drugs for spinal pain: A systematic review and meta-analysis', Annals of the Rheumatic Diseases, 76, pp. 1269 - 1278, http://dx.doi.org/10.1136/annrheumdis-2016-210597

Day RO, 2017, 'Pharmacokinetics of Metformin in Patients Receiving Regular Hemodiafiltration (vol 68, pg 990, 2016)', AMERICAN JOURNAL OF KIDNEY DISEASES, 69, pp. 870 - 870, http://dx.doi.org/10.1053/j.ajkd.2017.03.016

Kamel B; Graham GG; Williams KM; Pile KD; Day RO, 2017, 'Clinical Pharmacokinetics and Pharmacodynamics of Febuxostat', Clinical Pharmacokinetics, 56, pp. 459 - 475, http://dx.doi.org/10.1007/s40262-016-0466-4

Day RO, 2017, 'Introduction to the Special Section: Phase I Clinical Trials', Therapeutic Innovation and Regulatory Science, 51, pp. 274 - 275, http://dx.doi.org/10.1177/2168479017706513

Day RO; Snowden L; McLachlan AJ, 2017, 'Life-threatening drug interactions: what the physician needs to know', Internal Medicine Journal, 47, pp. 501 - 512, http://dx.doi.org/10.1111/imj.13404

Day RO; Kannangara DRW; Stocker SL; Carland JE; Williams KM; Graham GG, 2017, 'Allopurinol: insights from studies of dose–response relationships', Expert Opinion on Drug Metabolism and Toxicology, 13, pp. 449 - 462, http://dx.doi.org/10.1080/17425255.2017.1269745

Ghinea N; Lipworth W; Day R; Hill A; Dore GJ; Danta M, 2017, 'Importation of generic hepatitis C therapies: bridging the gap between price and access in high-income countries', The Lancet, 389, pp. 1268 - 1272, http://dx.doi.org/10.1016/S0140-6736(16)32051-7

Braithwaite J; Westbrook J; Coiera E; Runciman WB; Day R; Hillman K; Herkes J, 2017, 'A systems science perspective on the capacity for change in public hospitals', Israel Journal of Health Policy Research, 6, http://dx.doi.org/10.1186/s13584-017-0143-6

Mathieson S; Maher CG; McLachlan AJ; Latimer J; Koes BW; Hancock MJ; Harris I; Day RO; Billot L; Pik J; Jan S; Lin CWC, 2017, 'Trial of pregabalin for acute and chronic sciatica', New England Journal of Medicine, 376, pp. 1111 - 1120, http://dx.doi.org/10.1056/NEJMoa1614292

Lyell D; Magrabi F; Raban MZ; Pont LG; Baysari MT; Day RO; Coiera E, 2017, 'Automation bias in electronic prescribing', BMC Medical Informatics and Decision Making, 17, pp. 28, http://dx.doi.org/10.1186/s12911-017-0425-5

Baysari MT; Tariq A; Day RO; Westbrook JI, 2017, 'Alert override as a habitual behavior - A new perspective on a persistent problem', Journal of the American Medical Informatics Association, 24, pp. 409 - 412, http://dx.doi.org/10.1093/jamia/ocw072

Leung S; Zheng WY; Sandhu A; Day R; Li L; Baysari M, 2017, 'Feedback and training to improve use of an electronic prescribing system: A randomised controlled trial', Studies in Health Technology and Informatics, 239, pp. 63 - 69, http://dx.doi.org/10.3233/978-1-61499-783-2-63

Kannangara DRW; Graham GG; Wright DFB; Stocker SL; Portek I; Pile KD; Barclay ML; Williams KM; Stamp LK; Day RO, 2017, 'Individualising the dose of allopurinol in patients with gout', British Journal of Clinical Pharmacology, 83, pp. 2015 - 2026, http://dx.doi.org/10.1111/bcp.13307

Baysari MT; Gigante JD; Moran M; Sandaradura I; Li L; Richardson KL; Sandhu A; Lehnbom EC; Westbrook JI; Day RO, 2017, 'Redesign of computerized decision support to improve antimicrobial prescribing', Applied Clinical Informatics, 8, pp. 949 - 963, http://dx.doi.org/10.4338/ACI2017040069

, 2017, 'Erratum: Guideline development for the management of gout: role of combination therapy with a focus on lesinurad [Corrigendum].', Drug Des Devel Ther, 11, pp. 3589 - 3590, http://dx.doi.org/10.2147/DDDT.S158965

Walter SR; Day RO; Gallego B; Westbrook JI, 2017, 'The impact of serious adverse drug reactions: a population‐based study of a decade of hospital admissions in New South Wales, Australia', British journal of clinical pharmacology, 83, pp. 416 - 426

Smith FC; Kumar SS; Furlong TJ; Gangaram SV; Greenfield JR; Stocker SL; Graham GG; Williams KM; Day RO, 2016, 'Pharmacokinetics of Metformin in Patients Receiving Regular Hemodiafiltration', American Journal of Kidney Diseases, 68, pp. 990 - 992, http://dx.doi.org/10.1053/j.ajkd.2016.08.017

Ní Chróinín D; Neto HM; Xiao D; Sandhu A; Brazel C; Farnham N; Perram J; Roach TS; Sutherland E; Day R; Beveridge A, 2016, 'Potentially inappropriate medications (PIMs) in older hospital in-patients: Prevalence, contribution to hospital admission and documentation of rationale for continuation', Australasian Journal on Ageing, 35, pp. 262 - 265, http://dx.doi.org/10.1111/ajag.12312

Moon J; Kumar SS; Graham GG; Baysari MT; Williams KM; Chen W; Viardot A; Greenfield JR; Day RO, 2016, 'Trends in metformin utilisation and dose appropriateness in Australia', European Journal of Clinical Pharmacology, 72, pp. 1489 - 1496, http://dx.doi.org/10.1007/s00228-016-2117-y

day RO, 2016, 'Ganciclovir - Hypoglycaemia', WHO SIGNAL, pp. 15 - 18

Nguyen AD; Baysari MT; Kannangara DRW; Tariq A; Lau AYS; Westbrook JI; Day RO, 2016, 'Mobile applications to enhance self-management of gout', International Journal of Medical Informatics, 94, pp. 67 - 74, http://dx.doi.org/10.1016/j.ijmedinf.2016.06.021

Back to profile page